Literature DB >> 7784340

In vivo evaluation of a colon-specific drug delivery system: an absorption study of theophylline from capsules coated with azo polymers in rats.

G Van den Mooter1, C Samyn, R Kinget.   

Abstract

Azo polymers based upon 2-hydroxyethyl methacrylate, methyl methacrylate, and methacrylic acid, and containing N,N'-bis [(methacryloyloxyethyl)oxy(carbonylamino)]azobenzene as azo aromatic agent were evaluated in vivo as coating for colon-specific drug delivery. The gastrointestinal absorption of theophylline from capsules coated with the azo polymers was examined in the proximal part of the small intestine and the cecum of male Wistar rats. The capsules were surgically inserted in the region of interest. The plasma concentration of the drug was higher when the capsules were inserted in the cecum as compared to the small intestine. The appearance of theophylline in the plasma when capsules were administered in the small intestine can be attributed to simple diffusion of the drug through the swollen polymer coating. Release and absorption from the cecum is the combined results of diffusion and degradation of the azo polymer coatings by bacterial azo reductase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784340     DOI: 10.1023/a:1016283027139

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Hydrogels for site-specific oral drug delivery: synthesis and characterization.

Authors:  H Brøndsted; J Kopecek
Journal:  Biomaterials       Date:  1991-08       Impact factor: 12.479

2.  Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device.

Authors:  A H Staib; D Loew; S Harder; E H Graul; R Pfab
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Gastrointestinal pH measurement in rats: influence of the microbial flora, diet and fasting.

Authors:  F W Ward; M E Coates
Journal:  Lab Anim       Date:  1987-07       Impact factor: 2.471

4.  A new approach to the oral administration of insulin and other peptide drugs.

Authors:  M Saffran; G S Kumar; C Savariar; J C Burnham; F Williams; D C Neckers
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

5.  The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery.

Authors:  G Van den Mooter; C Samyn; R Kinget
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

6.  A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria.

Authors:  D R Friend; G W Chang
Journal:  J Med Chem       Date:  1984-03       Impact factor: 7.446

7.  In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.

Authors:  A Rubinstein; R Radai; M Ezra; S Pathak; J S Rokem
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

8.  A polymeric drug for treatment of inflammatory bowel disease.

Authors:  J P Brown; G V McGarraugh; T M Parkinson; R E Wingard; A B Onderdonk
Journal:  J Med Chem       Date:  1983-09       Impact factor: 7.446

9.  Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation.

Authors:  H Brøndsted; J Kopecek
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

10.  Drug glycosides: potential prodrugs for colon-specific drug delivery.

Authors:  D R Friend; G W Chang
Journal:  J Med Chem       Date:  1985-01       Impact factor: 7.446

  10 in total
  3 in total

Review 1.  ["Targeted delivery" in the gastrointestinal tract].

Authors:  C S Leopold
Journal:  Med Klin (Munich)       Date:  1999-02-15

2.  Colon targeted drug delivery systems: a review on primary and novel approaches.

Authors:  Anil K Philip; Betty Philip
Journal:  Oman Med J       Date:  2010-04

3.  Gut microbiota-driven drug metabolism in inflammatory bowel disease.

Authors:  Femke Crouwel; Hans J C Buiter; Nanne K de Boer
Journal:  J Crohns Colitis       Date:  2020-07-11       Impact factor: 9.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.